Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voluven in Major Elective Surgery
NCT01127477Phase 3Completed
- Sponsor
- Fresenius
- Start
- May 2010
- Primary completion
- Dec 2010
- Modality
- Polymer-based Nanoparticles, Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Volulyte in hypovolemia, sponsored by Fresenius. Started May 2010; status: completed.
02
Drugs
Volulyte
03
Conditions
hypovolemia
Beyond the preview
Go deeper on NCT01127477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01127477.